Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study.

Patient education and counseling - 1 May 2017

Guan Yue, Roter Debra L, Erby Lori H, Wolff Jennifer L, Gitlin Laura N, Roberts J Scott, Green Robert C, Christensen Kurt D

Abstract excerpt

OBJECTIVE: To describe the impact of genetic information on Alzheimer's disease (AD) risk communication to patients with mild cognitive impairment (MCI) and their visit companions. METHODS: Participants of the fourth REVEAL Study trial were randomized to receive AD risk assessments with or without genotype results. We coded 79 audio recorded risk disclosure sessions with the Roter Interaction Analysis System....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Cognitive Dysfunction

Share to Communication

Share to Genetic Counseling

Share to Physician-Patient Relations

Share to Truth Disclosure

Source

Open in PubMed Open full text

Identifiers

PMID: 28012682
DOI: 10.1016/j.pec.2016.12.005
PMCID: PMC5400683

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study.PMID 28012682Read ↗

Distinct communication patterns during genetic counseling for late-onset Alzheimer's risk assessment.Semantic proximity Read ↗

The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease.Semantic proximity Read ↗

Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.Semantic proximity Read ↗

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Semantic proximity Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.Semantic proximity Read ↗

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.Semantic proximity Read ↗

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.Semantic proximity Read ↗

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.Semantic proximity Read ↗

More Than Results: A Qualitative Study on the Role of Person-Centered Genetic Counseling in Parkinson’s Disease ResearchSemantic proximity Read ↗

CONNECT4 APOE: A randomized trial of telephone versus real-time two-way videoconference for disclosure of APOE genotype results in cognitively unimpaired adults.Semantic proximity Read ↗

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.